About this trial
The aim of this cohort study is to record, evaluate and compare the surgical, oncological as well as the functional outcome and Quality of life after mesorectal excision for rectal cancer
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Men and Women >18 years
Patients with rectal cancer
Underwent mesorectal excision
Agreed to fill in a validated questionnaires before surgery and after stoma reversal
Disqualifiers
Age < 18
No informed consent (no general consent, no consent to use personal data for research purpose)
Trial population
Patients with rectal cancer who benefit from surgical resection
Trial design
Cohort
Prospective
Treatments tested in this trial
Total mesorectal excision for rectal cancer
Procedure/Surgery
Treatment groups
Trial outcomes
Primary outcomes
Perioperative mortality
Reporting perioperative mortality with Clavien-Dindo \& Comprehensive Complications Index
Age
Age (years)
Body mass index
BM (kg/m2)
Gender
Sex (male, female)
Secondary outcomes
Perioperative treatment
Chemoradiation before or after surgery, other treatments necessary
Surgery time
Duration of surgery in minutes
Length of hospital stay
Length of hospital stay in days
Readmission rate
Number of patients readmitted within 90 days of index surgery divided by the total number of patients operated
Sponsors and contacts
Click on the lead sponsor to view all of their trials.